Zevra Therapeutics to Participate at Upcoming Investor Conferences
Zevra Therapeutics, Inc. (ZVRA)
Company Research
Source: GlobeNewswire
CELEBRATION, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the treatment of rare diseases, today announced that Neil F. McFarlane, President and Chief Executive Office of Zevra, will participate in the following December investor events. Piper Sandler 36th Annual Healthcare Conference, on Wednesday, December 4, 2024, at 10:30 a.m. ET.Oppenheimer Movers in Rare Disease Summit Elevator Pitches from Rare Disease Companies with Key Near-term, Potentially Stock-moving Catalysts, on Thursday, December 12, 2024, at 2:45 p.m. ET as part of an invitation-only event hosted by Oppenheimer. Additionally, management will be available for one-on-one meetings with registered attendees at each conference. The live webcast of the Piper Sandler fireside chat will be accessible via “Events & Presentations” on the Investor Relations section of Zevra’s website at investors.zevr
Show less
Read more
Impact Snapshot
Event Time:
ZVRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZVRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZVRA alerts
High impacting Zevra Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ZVRA
News
- Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024 [Yahoo! Finance]Yahoo! Finance
- Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024GlobeNewswire
- Zevra Therapeutics Announces Organizational ChangesGlobeNewswire
- Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type CGlobeNewswire
- Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.MarketBeat
ZVRA
Earnings
- 11/12/24 - Miss
ZVRA
Sec Filings
- 12/6/24 - Form 8-K
- 11/22/24 - Form 8-K
- 11/14/24 - Form SCHEDULE
- ZVRA's page on the SEC website